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Abstract Cholesteryl sulfate (CS) is a minor component of cell 
membranes, also present in lipoproteins, and its exact function is 
unknown. Since oxidation of low density lipoproteins (LDL) is 
thought to be an important determinant of atherogenesis, we 
investigated the influence of CS enrichment on copper-mediated 
oxidation of LDL. CS was found to act as a pro-oxidant, as 
measured by lipid oxidation parameters. The results also suggest 
that these effects were dependent on the sulfate group since pure 
cholesterol or cholesteryl acetate did not promote Cu2÷-mediated 
oxidation. Our findings imply that CS may affect the oxidizabil- 
ity and hence the potential atherogenicity of LDL. 
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1. Introduction 
Although cholesteryl sulfate (CS) is widely distributed in 
tissues, its precise function has not been well established [1]. CS 
is a minor constituent of cells such as erythrocytes [2], sperma- 
tozoa [3] and of lipoproteins uch as low density lipoproteins 
(LDL) and chylomicrons [4]. Under certain conditions, CS can 
be used as a precursor for sulfated steroid hormones without 
desulfation [5]. Data are scarce about the factors that affect the 
quantity of CS in cells or lipoproteins. Plasma levels of CS are, 
however, greatly increased in some clinical conditions uch as 
in microsomal steroid sulfatase deficiency or in recessive X- 
linked ichthyosis [6]. In these patients, because of abnormal 
concentrations of CS, the electrophoretic mobility of LDL is 
greatly increased [7]. In addition, results from this laboratory 
indicate that hypercholesterolemic patients had higher plasma 
CS concentrations [8,9]. 
A key event in the pathogenesis of atherosclerosis is thought 
to be the formation of macrophage-derived foam cells by scav- 
enger receptor uptake of oxidized LDL [10,11]. In this paper, 
we report that CS has a pro-oxidant effect when supplemented 
in LDL as measured by monitoring the formation of conju- 
gated dienes, thiobarbituric acid reactive substances (TBARS) 
and lipid peroxides after incubation with copper. 
2. Materials and methods 
2.1. Materials 
Sterols and other chemicals were purchased from Sigma or Merck. 
CS and fl-sitosteryl sulfate was synthesized according to the method of 
Mumma [12]. They were purified by TLC and stored frozen under 
*Corresponding author. Fax: (33) 80 39 33 00. 
nitrogen or argon at -20°C. Pyridine and silylating reagent were from 
Supelco. 
2.2. Preparation and oxidation of LDL 
After an overnight fast, blood samples taken from volunteers by 
venipuncture were put into tubes containing disodium EDTA (1.5 mg/ 
ml). Plasma was separated in a cold centrifuge and LDL (1.019-1.055 
g/ml) were isolated by sequential u tracentrifugation. Pooled LDL were 
dialyzed against phosphate buffered saline (PBS) containing 100/IM 
EDTA. They were sterilized by passage through a Millipore filter (0.22 
pm) and stored under argon at 4°C in the dark for no longer than 15 
days. Sterols were incubated (0.2~).4% LDL-cholesterol) with LDL as 
follows: sterols in CH2ClJCH3OH (1/1, by volume) were evaporated to
dryness under nitrogen or argon in a glass tube, and LDL (200/zg/ml) 
were then added and left in the dark under argon at ambient tempera- 
ture with gentle swirling for 30 min. Just before the oxidation experi- 
ments, LDL were further purified by small column chromatography 
wrapped in aluminium foil to remove EDTA [13]. Oxidation of LDL 
(100/~g/ml) was carried out by exposure to 5 BM Cu 2+ (using CuSO4) 
at 37°C for up to 5 or 16 h. Oxidations were also carried out in the 
presence of the azo initiator, 2,2'-azobis(2-amidinopropane) dihydro- 
chloride (AAPH) obtained from Spiral (France); the final concentra- 
tion was 8 mM at 37°C under air [14]. 
2.3. Analytical procedures 
CS was measured in LDL using fl-sitosteryl sulfate as an internal 
standard according to the previously published method [8]. Lipid per- 
oxidation was measured by spectrophotometrically (234 nm) monitor- 
ing the formation of conjugated ienes [15] in a thermostatted cuvette 
holder maintained at 37°C (Beckman DU65 or DU640). The absorb- 
ance results were adjusted by curve fitting analysis of the initial sigmoid 
portion of the curve. The oxidation was also followed by measuring 
TBARS released in the medium and expressed in malondialdehyde 
(MDA) equivalents as described [16]. Lipid peroxides (LPO) were 
measured as described [17]. Agarose gel-electrophoresis (0.5%) was 
performed with a Beckman Paragon lipoprotein electrophoresis kit. 
Proteins were assayed by the Lowry method [18]. 
3. Results and discussion 
In initial experiments, the influence of CS on the formation 
of conjugated ienes of LDL in the presence of Cu 2÷ was eval- 
uated. As illustrated in Fig. 1, the change in the absorbance at 
234 nm of native LDL follows three phases [15]. Firstly, there 
is a lag phase during which endogenous antioxidants are pro- 
gressively consumed. Next, there is the propagation phase with 
a rapid increase in absorbance. Finally, the last phase is the 
decomposition of hydroperoxides during which no further in- 
crease in absorbance occurs. LDL incubated with CS showed 
a higher initial amount of dienes and a decrease in the lag time. 
The leftward shift of the progress curves were correlated with 
increasing concentrations of CS. These results were also ob- 
tained with LDL from different donors. The rate vs. time plot 
of the inset of Fig. 1 is the first derivative dA/dt with a maxi- 
mum obtained by computer analysis. A value of 90.8 + 0.6 mn 
was calculated for native LDL (N-LDL). These peak times 
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Fig. 1. Monitoring of Cu2+-initiated oxidation of LDL. Native LDL (100 #g/ml) oxidation was studied at 37°C by conjugated dienes absorption at 
234 nm with 5 #M Cu =+. Native LDL was incubated with either 1.5, 3 or 6 #M CS as described in section 2. The inset shows the first derivative, 
i.e. change of rates of oxidation as a function of time, which was computed to obtain the time for half maximum diene formation. 
decreased to 89.5 + 1.0, 82.7 + 1.3 and 72.8 + 1.0 mn for LDL 
incubated with 1.5, 3 and 6 #M CS, respectively. 
The results of t ime-course studies dealing with the release of 
TBARS and LPO in the medium of CuZ÷-oxidized LDL were 
comparable to previous studies. In our conditions, the produc- 
tion of TBARS and LPO leveled off or decreased after about 
2 h and 3 h, respectively. Consequently, maximum differences 
between samples could be defined at shorter incubation times. 
We thus decided to perform our investigations with incubation 
times of 30 or 60 min for TBARS and of 60 or 180 rain for LPO. 
CS-enriched LDL showed an increased product ion of TBARS 
(Fig. 2A) and LPO (Fig. 2B) as compared to control LDL. This 
enhanced lipid oxidation was concentration-dependent,  si ce at 
30 min the increase in TBARS reached about +350% and 
+720% with respect to controls for 3 and 6 #M CS, respec- 
tively. Similar enhancements were obtained for LPO (at 60 min: 
Table 1 
Effects of EDTA and BHT on Cu=*-mediated oxidation of native LDL 
(N-LDL) and CS-enriched LDL (CS-LDL) 
TBARS (nmol MDA/mg) 
N-LDL 22.6 + 1.6 
+EDTA 4.3 + 1.1 
+BHT 4.5 + 1.8 
CS-LDL 71.3 + 4.8* 
+EDTA 6.8 + 2.2 
+BHT 7.4 _+ 3.1 
The reactions were initiated by addition of 5 #M copper, stopped at 60 
min, and TBARS assayed as described in section 2 (difference from 
N-LDL: P < 0.001) for comparison between N-LDL and CS-LDL. 
+ 196 and + 450% for 3 and 6#M CS, respectively). As reported 
previously [7,19], we confirmed that enrichment of LDL with 
CS increased the electrophoretic mobil ity of these lipoproteins. 
Although in the present work we did not measure the precise 
CS concentrat ion that went into LDL, these data support idea 
that an effective incorporation took place. Furthermore,  in the 
presence of Cu 2÷, the data presented in Fig. 3 indicate that 
supplementing LDL with CS resulted in an increase in the 
electrophoretic mobil ity relative to controls (REM) for the 
different imes studied. 
The mechanism by which CS enhances lipid oxidation is 
Table 2 
Effect of cholesterol, cholesteryl acetate and sulfate on Cu2+-mediated 
LDL oxidation 
N-LDL CS-LDL CA-LDL C-LDL 
Dienes 
(~mol/mg) 101.7 + 11.8 413.6 + 22.6* 129.9 + 12.4 106.4 __ 14.1 
TBARS 
(nmol MDA/ 20.8 _+ 1.4 63.5 _+ 3.8* 24.6 _+ 2.9 21.2 _+ 1.2 
mg) 
LPO (nmol mg) 25.4 _+ 0.6 26.8 _ 2.1" 7.2 _+ 0.9 6.8 _+ 1.0 
REM 1.50 3.35 1.55 1.65 
Native LDL (N-LDL) were incubated with 6 #M of either cholesteryl 
sulfate (CS), cholesteryl acetate (CA) or pure cholesterol (C), and oxi- 
dized with 5 #M Cu 2+. Dienes, thiobarbituric acid reactive substances 
(TBARS), lipoperoxides (LPO) and electrophoretic mobility relative to 
N-LDL (REM) were measured as described in section 2 at 80 rain, 60 
min, 180 min and 60 min, respectively. Results of triplicate assays are 
given as means _+ S.D., except for REM which are the average of 
duplicate values (difference from N-LDL: P < 0.001). 
D. Blache et al . /FEBS Letters 362 (1995) 19~200 199 
rn  
~ 8O 
-¢ 
0 
G 
O_ 
E 
0 
E 
C 
30 mn 60 mn , 
60 
40 
20 
0 
CTL 3#14 CS 6~M CS CTk 3#M CS 6JM CS 
0 
0-  
(3) 
E 
I/) 
0 
E 
3O 
20 
lO 
0 
60 mn 180 mn 
CTL 3id4 CS 6/1t4 CS CTL 3~ C5 6~H CS 
Fig. 2. Effect of CS on Cu2*-initiated LDL oxidation. Native LDL 
(CTL) were incubated with 3 or 6/~M CS as described insection 2and 
oxidized with 5 ktM Cu 2+. The reaction was stopped at different times 
by the addition of EDTA and BHT (100 and 50 ,uM, respectively) and 
analyzed for TBARS (A) and LPO (B). The results are representative 
of 3 experiments performed in triplicate. *P < 0.001 when CTL was 
compared with CS. 
unknown but results presented in Table 1 suggest that it could 
be by stimulating oxidative processes. When LDL supple- 
mented with 6 ~M CS were incubated with either EDTA or 
BHT, the Cu2+-initiated oxidation was inhibited. To determine 
whether the pro-oxidant property of CS was dependent on the 
sulfate group, pure cholesterol and cholesteryl acetate were 
tested for their effects on the oxidizability of LDL at the same 
concentration (6 pM). As can be seen in Table 2, none of these 
compounds showed a pro-oxidant effect when added to LDL, 
suggesting that oxidation was specifically due to the presence 
of the sulfate group. 
The results presented in Table 3 suggest hat interactions 
between copper ions and the sulfate group may exist. These 
data indicate that no supplementary oxidation was obtained 
with CS when carried out using the azo initiator AAPH. This 
oxidation system is not dependent on the decomposition of
lipid peroxides. 
The presence of a sulfate group on the cholesterol molecule 
provides important biological properties uch as membrane 
stability [2,3], regulation of cholesterol biosynthesis [7,19] or 
inhibition of lecithin: cholesterol acyltransferase [20]. CS has 
also been found to display a strong ability to trigger the activa- 
tion of factor XII [20] and thus to be involved in the intrinsic 
coagulation system. CS accumulates in X-linked ichthyosis pa- 
tients deficient in aryl sulfatase [6,7], and CS is implicated in 
the skin scaling abnormalities of these subjects [21]. Increased 
plasma CS concentrations have also been found in hyper- 
cholesterolemic and cirrhotic patients, although plasma levels 
were less elevated than in the genetic disorder [8,9,22]. 
Since, CS concentration measured inthe LDL prepared from 
three different normolipidemic volunteer donors, was 
2.99 + 0.16 nmol/mg protein, CS enrichments of LDL of 1.5, 
3 and 6/.tM would represent increases of about 1.5, 2 and 6 
times the endogenous concentration f CS in these subjects. In 
normal LDL, the ratio of CS to total cholesterol (TC) is less 
than 0.1% [22]. The various preparations tested in this study 
resulted in a ratio of about 0.5-2%, which is in the reported 
range for patients with recessive X-linked ichthyosis [19]. Al- 
though calculated in total plasma, the CS/TC ratio for cirrhot- 
ics was roughly 0.33% and close to normal (0.14%) in hyper- 
cholesterolemics [8,9,22]. Therefore these findings may have 
important implications in the pathophysiology of these dis- 
eases. 
The mechanism by which CS influences LDL oxidative sus- 
ceptibility has not been defined. Although the sulfate group 
seems to play a role, its precise involvement has not been 
defined. One possibility is that Cu 2+ ions bind more to the 
CS-enriched LDL because of the presence of the negatively 
charged sulfate groups. It has been recently demonstrated that 
a finite number of saturable pro-oxidant copper binding sites 
exist within the LDL particle [23]. In addition, this number may 
vary from one subject to another. However, the nature of these 
binding sites and the reason for their variation is not clear. In 
the procedures used in the present paper, the endogenous per- 
oxide content of the isolated LDL is an important determinant 
of the oxidizability of LDL for the copper-mediated oxidation, 
whereas using AAPH the mechanism in less dependent on the 
lipid peroxides. Besides fatty acid peroxides [24,25], cholesterol 
peroxides potentiated the Cu2+-initiated LDL oxidation [26]. 
However, these latter compounds did not account for the ef- 
fects observed with CS in the present study since TLC-repuri- 
fled CS was as pro-oxidant as stock CS. 
To assess whether the in vitro data presented in this paper 
are relevant in human pathology, studies are now in progress 
in our laboratories to investigate he susceptibility ooxidation 
9 
8 • native LDL [ ]  
7 • 3/IM C5 LDL [ ]  
6 • 6#H CS L~ [ ]  T 
4 
3 
2 
1 
0 ' ' '1 ' , '  
0 30 60 90 12o 240 16h 
TIME (mn) 
Fig. 3. Effect of CS on the electrophoretic mobility of Cu2+-initiated 
oxidation of LDL. Native LDL and LDL incubated with 3 or 6/IM 
CS were oxidized with Cu >. The reaction was stopped for the times 
shown as in Fig. 2 and the samples were subjected to agarose gel- 
electrophoresis. Results are expressed relative to native LDL without 
Cu z÷ (REM). The maximum changes inmobility obtained for 16 h were 
25 mm for native LDL and 30 and 32.5 mm for 3 $tM and 6 pM 
CS-enriched LDL, respectively. Results are representative of two exper- 
iments performed in duplicate or triplicate over a 16 h time-course. 
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Table 3 
Effect of CS on AAPH-induced LDL oxidation 
Time (min) N-LDL CS-LDL 
TBARS 2 h 7.8 + 1.2 8.1 + 1.4 
4 h 16.4 _+ 2.3 17.4 + 2.6 
REM 0 h 1.0 1.0 
2 h 1.85 1.90 
4 h 2.25 2.20 
AAPH-induced oxidations were carried out on native LDL (N-LDL) 
and CS-incubated LDL (CS-LDL) at 37°C under air and the reactions 
stopped by adding 100/IM EDTA and 50/IM BHT. Final LDL and 
AAPH concentrations were 0.2 mg/ml and 8 raM, respectively. 
TBARS, expressed in nmol MDA/mg protein (n = 3), and electro- 
phoretic mobility relative to N-LDL (REM) were measured as de- 
scribed in section 2. 
of LDL from patients with endogenous high levels of CS such 
as those with X-linked ichthyosis and hypercholesterolemia. 
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